2025-12-08
9 分钟For Scientific American Science Quickly, I'm Kendra Peer Lewis in for Rachel Feldman.
You're listening to our weekly science news roundup.
First up, vaccines.
On Thursday and Friday of last week,
the Center for Disease Control and Prevention's Advisory Committee on Immunization Practices,
or ACIP, met to review and vote on recommendations for official US vaccine guidelines.
Here to give us an update is Lauren Young,
Associate Editor for Health and Medicine at Scientific American.
The major point of discussion was the hepatitis B birth dose of the vaccine.
So this has historically been, since 1991,
a three-dose regimen that typically begins hours after birth,
regardless of whether or not a parent has tested positive or negative for the virus that causes this disease.
So after a lot of heated discussion and deliberations and tabling this vote twice,
first in September and again this past Thursday,
the panel voted to recommend parents would need to consult with a healthcare provider about when to give a baby their first dose of the vaccine.
So long as the birthing parent tested negative for the disease.
And finally, after a lot of discussion and contention,
the ACIP members also passed a second vote to recommend that parents discuss the subsequent doses of that three-dose regimen with a health care provider based on blood tests of the newborn's immunity levels.
Those are the protective antibody titers.
It's important to note that we have a lot of data and studies that clearly demonstrate the previous three-dose regimen beginning at birth helped drastically reduce cases of childhood hepatitis B.